Bristol Myers Squibb to lay off 2,200 jobs under $1.5bn cost savings initiative
The “strategic productivity initiative” to be executed by the American pharmaceutical company will also involve reducing management layers, rationalising its pipeline, consolidating sites, and decreasing third-party spending